跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LIXIANA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
LIXIANA
Authorized
STANDARD
LIXIANA
SERVIER CANADA INC
🇨🇦 Health Canada
Approval Date
Apr 6, 2026
Approval ID
073960777c08984c
Company
SERVIER CANADA INC
Type
Standard
Approval Details
Approval Id
073960777c08984c
Drug Approval Canada Name
LIXIANA
Product Name
LIXIANA
Status
Cancelled Post Market
Status Date
2026-02-24
Original Market Date
2017-04-25
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
PRESCRIPTION
Ahfs
20:12.04.14
Atc Original
B01AF03 EDOXABAN
Aig Number
0158530003
Company Name
SERVIER CANADA INC
Company Address
270 3224 Avenue Jean-Béraud Laval Quebec Canada H7T 2S4
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Apr 6, 2026
Approval ID
073960777c08984c
Type
Standard
Back to Health Canada Approvals